Literature DB >> 12429988

Gene expression pattern following photodynamic treatment of the carcinoma cell line A-431 analysed by cDNA arrays.

Thomas Verwanger1, Renata Sanovic, Fritz Aberger, Anna-Maria Frischauf, Barbara Krammer.   

Abstract

The photosensitizer protoporphyrin IX, endogenously accumulated from the precursor aminolevulinic acid, is a successful agent in photodynamic tumor therapy. In spite of encouraging clinical results, the basic mechanisms leading to cell death are not fully understood. We therefore set out to analyse the alteration of the gene expression pattern in the squamous cell carcinoma cell line A-431 after photodynamic treatment with endogenous protoporphyrin IX. Radioactively labelled cDNAs from untreated and treated cells were hybridized onto UniGene cDNA array filters containing lysed bacterial colonies with inserts representing approximately 32000 different human transcripts. Differentially expressed genes were identified and verified on sub-arrays containing only the candidate genes. We found increased expression of heat shock protein 70 and of the immediate early genes p55-c-fos and c-jun, may be due to oxidative stress and increased levels of intracellular calcium after photoactivation of protoporphyrin IX. Increased expression of heme oxygenase-1 following dark incubation was not further increased by irradiation and therefore probably caused by the need for heme degradation. Presumably heat shock protein 70 and heme oxygenase-1 serve for cell protection. Though similar results have been found for photodynamic treatment with external porphyrin-based photosensitizers, this is the first report about induction of the genes described above by (photoactivated) endogenous protoporphyrin IX.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429988

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

Review 3.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

4.  Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity.

Authors:  D Nowis; M Legat; T Grzela; J Niderla; E Wilczek; G M Wilczynski; E Głodkowska; P Mrówka; T Issat; J Dulak; A Józkowicz; H Waś; M Adamek; A Wrzosek; S Nazarewski; M Makowski; T Stokłosa; M Jakóbisiak; J Gołab
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

5.  The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells.

Authors:  Pei-Wen Yang; Mien-Chie Hung; Ching-Yueh Hsieh; En-Chi Tung; Ying-Hao Wang; Jui-Chang Tsai; Jang-Ming Lee
Journal:  Lasers Med Sci       Date:  2012-05-15       Impact factor: 3.161

6.  Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy.

Authors:  Robert Kammerer; Alexander Buchner; Patrick Palluch; Thomas Pongratz; Konstantin Oboukhovskij; Wolfgang Beyer; Ann Johansson; Herbert Stepp; Reinhold Baumgartner; Wolfgang Zimmermann
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

7.  Mapping of oxidative stress responses of human tumor cells following photodynamic therapy using hexaminolevulinate.

Authors:  Lina Cekaite; Qian Peng; Andrew Reiner; Susan Shahzidi; Siri Tveito; Ingegerd E Furre; Eivind Hovig
Journal:  BMC Genomics       Date:  2007-08-13       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.